Women are twice as likely as men to have major depressive disorder (MDD) during their lifetimes, and women are particularly at risk during the menopausal transition (including perimenopause and early menopause), which can last many years. Typically starting after age 40, this period is characterized by fluctuations in hormones and various physical symptoms like hot… Read More »
New research uses over half a million Facebook status updates to predict depression diagnoses in people at risk. Your Facebook posts may predict whether you will develop depression. Depression is one of the most widespread mental health problems in the United States, with over 16 million adults having experienced at least one major depressive episode… Read More »
In 2015, we first reported on SAGE-547 (SAGE Therapeutics), a new medication for the treatment of severe postpartum depression (PPD). SAGE-547, now called brexanolone, is an allosteric modulator of GABA-A receptors. We saw the preliminary results of the Sage Therapeutics Phase 3 Hummingbird Program earlier this year. Now we have the final set of results… Read More »
Men who have erectile dysfunction, prostate problems, or other urologic conditions are often at higher risk for depression and sleep disorders. Physicians need to screen for this and refer them for specialist care. Men with urologic conditions such as erectile dysfunction are more likely to have depression and sleep disorders. This was the main conclusion… Read More »